Source: FinanzNachrichten

Propel Labs: Bio-Rad Expands Its Cell Biology Portfolio With High Performance Flow Cytometer

HERCULES, CA and FORT COLLINS, CO -- (Marketwired) -- 02/08/16 -- Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) and Propel Labs today announced that Bio-Rad has acquired a high performa...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100